Your browser doesn't support javascript.
loading
In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"
Thomas, Nicholas J; Myall, Nathaniel J; Sun, Fangdi; Patil, Tejas; Mushtaq, Rao; Yu, Chandler; Sinha, Sumi; Pollom, Erqi L; Nagpal, Seema; Camidge, D Ross; Rusthoven, Chad G; Braunstein, Steve E; Wakelee, Heather A; McCoach, Caroline E.
Afiliação
  • Thomas NJ; Division of Medical Oncology, UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California.
  • Myall NJ; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Sun F; Division of Medical Oncology, UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California.
  • Patil T; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Mushtaq R; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Yu C; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Sinha S; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Pollom EL; Department of Radiation Oncology, Stanford Cancer Institute, Stanford, California.
  • Nagpal S; Department of Neurology, Stanford University, Stanford, California.
  • Camidge DR; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Rusthoven CG; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.
  • Braunstein SE; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Wakelee HA; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • McCoach CE; Division of Hematology/Oncology, University of California San Francisco, San Francisco, California; Genentech Inc., South San Francisco, California. Electronic address: caroline.mccoach@ucsf.edu.
J Thorac Oncol ; 17(2): e12-e14, 2022 02.
Article em En | MEDLINE | ID: mdl-35074229
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article